Schedule 13D ownership disclosure
TITAN PHARMACEUTICALS INC
Security class unavailable · CUSIP: 888314101
Event date: 2016-05-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-16-000811
- Form type
- SC 13D
- Filer
- ATP Life Science Ventures, L.P.
- CIK
- CIK 1593440
- Filed
- Jun 03, 2016
- Reporting period
- May 27, 2016
- Description
- Schedule 13D beneficial ownership